Supernus Pharmaceuticals (SUPN) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Q3 2025 value amounting to -$13.5 million.
- Supernus Pharmaceuticals' Other Gross PP&E Adjustments fell 17244.65% to -$13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.5 million, marking a year-over-year decrease of 17244.65%. This contributed to the annual value of -$6.1 million for FY2024, which is 4800.85% up from last year.
- Supernus Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$13.5 million in Q3 2025, which was down 17244.65% from -$7.8 million recorded in Q2 2025.
- Over the past 5 years, Supernus Pharmaceuticals' Other Gross PP&E Adjustments peaked at $25.3 million during Q1 2021, and registered a low of -$36.4 million during Q2 2022.
- Over the past 5 years, Supernus Pharmaceuticals' median Other Gross PP&E Adjustments value was -$7.8 million (recorded in 2025), while the average stood at -$3.6 million.
- The largest annual percentage gain for Supernus Pharmaceuticals' Other Gross PP&E Adjustments in the last 5 years was 17346.28% (2021), contrasted with its biggest fall of 25153.87% (2021).
- Quarter analysis of 5 years shows Supernus Pharmaceuticals' Other Gross PP&E Adjustments stood at -$28.7 million in 2021, then surged by 39.11% to -$17.5 million in 2022, then skyrocketed by 32.87% to -$11.7 million in 2023, then soared by 48.01% to -$6.1 million in 2024, then crashed by 121.65% to -$13.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$13.5 million for Q3 2025, versus -$7.8 million for Q2 2025 and $14.9 million for Q1 2025.